Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.85 USD | +0.89% |
|
+0.17% | -18.46% |
01:37pm | ABL Bio, BMS Collaborate on Gastric Cancer Treatment Trial | MT |
07/06 | Geron shares surge after U.S. FDA approves blood disorder drug | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.46% | 8.41TCr | |
+47.30% | 77TCr | |
-6.34% | 35TCr | |
+19.32% | 33TCr | |
+8.89% | 30TCr | |
+18.81% | 25TCr | |
-1.88% | 22TCr | |
+10.91% | 22TCr | |
+4.86% | 16TCr | |
-2.70% | 16TCr |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Transcript : Bristol-Myers Squibb Company Presents at Guggenheim Securities Radiopharmaceuticals Day, May-13-2024 11